Gene: PRG4
Official Full Name: proteoglycan 4provided by HGNC
Gene Summary: The protein encoded by this gene is a large proteoglycan that is synthesized by chondrocytes located at the surface of articular cartilage and by some synovial lining cells. This protein contains both chondroitin sulfate and keratan sulfate glycosaminoglycans. It functions as a boundary lubricant at the cartilage surface and contributes to the elastic absorption and energy dissipation of synovial fluid. Mutations in this gene result in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32139 | PRG4 Knockout cell line (HeLa) | Human | PRG4 | 1:3~1:6 | Negative | Online Inquiry |
PRG4 Gene Knockout Cell Lines are specifically engineered cellular models that lack the expression of the proteoglycan 4 (PRG4) gene, which encodes lubricin, a key glycoprotein that plays a critical role in joint lubrication and protecting articular cartilage from wear and tear. These cell lines serve as invaluable tools for researchers examining the physiological and pathological roles of PRG4 in various biological systems, particularly in joint health and regeneration.
The primary mechanism by which PRG4 impacts joint function involves the secretion of lubricin into synovial fluid, where it reduces friction between articular surfaces during movement. By employing PRG4 Gene Knockout Cell Lines, researchers can dissect the specific pathways impacted by the absence of this critical protein. This can advance our understanding of joint diseases, such as osteoarthritis, by allowing scientists to model pathological conditions that arise from the lack of synovial lubrication.
Scientifically significant, these cell lines find applications in both basic research and translational medicine. In research settings, they enable comprehensive studies into cellular responses, gene expression profiles, and the biochemical pathways influenced by PRG4 depletion. Clinically, this knowledge can pave the way for novel therapeutic interventions aimed at enhancing lubricin production or mimicking its effects to prevent or treat joint degenerative diseases.
Unique to PRG4 Gene Knockout Cell Lines is their precision and specificity, allowing for reproducible results and insights into the mechanistic basis of joint-related conditions. Unlike traditional knockout models, these cell lines provide a platform that is easier and more rapid to manipulate, saving time and resources while enhancing experimental efficiency.
For researchers and clinicians dedicated to understanding musculoskeletal health, the availability of PRG4 Gene Knockout Cell Lines signifies a leap forward in the quest for innovative treatments. Our company is committed to delivering high-quality, cutting-edge biological products backed by extensive expertise in cellular and molecular biology, ensuring that our customers have access to the tools necessary to advance scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.